A lesson from Morgan Housel: ‘Ideas don’t matter if you don’t communicate them effectively’
The Collaborative Fund partner answers our burning questions.
A private-equity firm bought Ancestry.com for $4.7B. Here’s what they might do with it.
Our insiders say Ancestry’s trove of DNA data is a huge moat.
What happens when Google barges in on your territory, in 2 charts
A deal with Google was sweet news for ADT and sour grapes for the competition.
Top takeaways from the antitrust Royal Rumble
One for each butt in the hot seat, plus a few more.
Sports are back — finally. Here’s how entrepreneurs would fix the viewing experience
Empty stadiums are creepy, but cardboard fans are creepier -- and virtual fans might be the creepiest.
A buzz-worthy buyer is snapping up the IP of one of America’s many troubled retail chains
Tai Lopez, better known as the “here in my garage” guy, has another turnaround project.
White space for plant-based milk, and Peacock charges into the streaming market
You can make jokes about that $9 latte, but plant-based milk is nothing to scoff about.
Which businesses got coronavirus relief money? Insights from the new data
A handful of industries received half the funds.
The UK government is taking a $500m stake in a bankrupt satellite company
The deal to acquire OneWeb puts the government on a collision course with Elon Musk’s Starlink.
It was a good day for the ‘-ade’ class of startup IPO’s
Lemonade and Accolade continued a recent run of successful Wall Street debuts.
A messaging app won a cat-and-mouse game with the Russian government
The government wanted in, but Telegram’s founder said nyet.
AI is helping scientists sort through heaps of coronavirus research
The tools are vital, because the mountain of medical research on COVID-19 is growing.
Meet the new upstart in the world of high-priced art sales
Loïc Gouzer, once dubbed “the daredevil of the art world,” is back.
These startups want to make your Zoomin’ a little more human
Video conferencing isn’t going away anytime soon, so some startups are making lemonade out of lemons.
A new player in email knocked over a bushel of debate about Apple’s App Store
Hey turned heads with its innovative approach to email, but quickly ran into an Apple problem.
The Supreme Court hands a major victory to LGBTQ workers
The justices said a major federal civil-rights law covers discrimination on the basis of sexual orientation and gender identity.
Some companies filed for bankruptcy, but their stocks are going bonkers anyway
Here’s why everyone’s got the hotz for Hertz.
One airline’s weird strategy for raising capital in a pandemic: selling its prized artworks
The sales may not help mend the airline’s reputation -- British lawmakers called it the company a “national disgrace.”
Nikola and Tesla are fighting it out over the future of trucking
You’re not losing your mind: Two companies named for the same dead inventor are jockeying for room in the fast lane.
More workers put the squeeze on their companies to support Black Lives Matter
Employees at Adidas, Microsoft, and other big companies are turning up the heat.
Reebok and partner gyms walk away from CrossFit after CEO’s ‘FLOYD-19’ tweet
When Greg Glassman spoke out, his company’s partners said they’d seen enough.
What to expect as New York City begins to reopen
Retailers, construction companies, manufacturers, and wholesalers can all get back to business, but some won’t do so right away.
Scientists funded by the Chan Zuckerberg Initiative are speaking out against Facebook
In a letter, 140+ scientists said the “spread of deliberate misinformation and divisive language” is antithetical to the initiative’s mission.
Trends turns 1: Our hits, misses, and strangest finds
A recap of what we got right and wrong.
Our pandemic pivot to Zoom Everything brought the company some big gains
Zoom’s Q1 revenues were up 169% over last year.
For better or worse, social media makes it impossible to look away
Social platforms are central to the booming protest movement. CEOs who lead them are feeling the heat.
The trading trends of 2 key biopharma stocks are raising eyebrows
Experts say fortuitously timed trades of Moderna and Gilead Sciences could draw scrutiny from regulators.
The plant-based meat wars are hitting the courts
A European court just blocked Nestlé from naming its burger brand “Incredible.”
“Entertaining, informative, keeps you coming back for more...”
